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Abstract
Background: Evidence is lacking on the differences between hospitalisation of people with dementia living in
nursing homes and those living in the community. The objectives of this study were: 1) to describe the frequency
of hospital admission among people with dementia in eight European countries living in nursing homes or in the
community, 2) to examine the factors associated with hospitalisation in each setting, and 3) to evaluate the costs
associated with it.
Methods: The present study is a secondary data analysis of the RightTimePlaceCare European project. A cross-
sectional survey was conducted with data collected from people with dementia living at home or who had been
admitted to a nursing home in the last 3 months, as well as from their caregivers. Data on hospital admissions at 3
months, cognitive and functional status, neuropsychiatric symptoms, comorbidity, polypharmacy, caregiver burden,
nutritional status, and falls were assessed using validated instruments. Multivariate regression models were used to
investigate the factors associated with hospital admission for each setting. Costs were estimated by multiplying
quantities of resources used with the unit cost of each resource and inflated to the year 2019.
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Results: The study sample comprised 1700 people with dementia living in the community and nursing homes.
Within 3 months, 13.8 and 18.5% of people living in nursing homes and home care, respectively, experienced ≥1
hospital admission. In the nursing home setting, only polypharmacy was associated with a higher chance of
hospital admission, while in the home care setting, unintentional weight loss, polypharmacy, falls, and more severe
caregiver burden were associated with hospital admission. Overall, the estimated average costs per person with
dementia/year among participants living in a nursing home were lower than those receiving home care.
Conclusion: Admission to hospital is frequent among people with dementia, especially among those living in the
community, and seems to impose a remarkable economic burden. The identification and establishment of an
individualised care plan for those people with dementia with polypharmacy in nursing homes, and those with
involuntary weight loss, accidental falls, polypharmacy and higher caregiver burden in the home care setting, might
help preventing unnecessary hospital admissions.
Keywords: Aged, Dementia, Geriatric syndrome, Home care, Hospitalisation, Nursing home
Background
Dementia is a major cause of disability and dependency
among older people worldwide and has a psychological,
social and economic impact on the persons affected,
their families and caregivers, and the society [1]. People
with dementia have increasing needs for care and super-
vision throughout the course of their disease, usually
leading to the need for support from relatives or other
informal caregivers and, when the needs of people with
dementia are increased, many of them need to receive
care in nursing homes (NH) [2].
Admission to hospital due to acute medical problems,
including the admission to the emergency departments,
is one of the events that people with dementia may ex-
perience throughout the course of the disease, irrespec-
tively of whether they live at their own home or at NH.
Despite the benefits of receiving specialized care, mul-
tiple negative health outcomes have been associated with
the admission to hospital of older people in general and
people with dementia in particular, including high risk
of delirium [3], functional decline [4], fall-related injuries
[5], nosocomial infections, pressure ulcers [6], and an
elevated risk of mortality [7, 8].
In a recent systematic review of the literature, Shep-
herd et al. (2019) concluded that people with dementia
are more frequently admitted to hospital than those
without dementia, and identified hospitalisation rates in
people with dementia between 0.37 and 1.26/person-year
in high-quality studies [9]. However, studies on people
with dementia that predominantly resided in long-term
nursing care facilities were excluded from this review.
Maxwell et al. (2015) reported an annual hospitalisation
rate of 0.10 per person-year among people with demen-
tia living in NH [10].
In their meta-analysis, Shepherd et al. (2019) found
strong evidence that multimorbidity, polypharmacy, and
lower functional ability are associated with hospital
admission, and strong evidence that dementia severity
alone is not associated [9]. However, there is a lack of
studies reporting on factors associated with hospitalisa-
tion among people with dementia living in NH.
Geriatric syndromes are known to predict an increased
likelihood of hospitalisation, affect quality of life [11], in-
crease the use and cost of health care, and raise overall
mortality among the general older population [12, 13].
However, relevant geriatric syndromes such as malnutri-
tion or falls have not been evaluated as potential factors
associated with hospital admissions in the studies involv-
ing people with dementia [9]. Furthermore, even if care-
givers of people with dementia have a crucial role in the
care and resource use in this population, only few stud-
ies have analyzed the effects that their psychological
wellbeing may have on the decisions of hospital admis-
sion of these people [14].
Even if the economic cost of dementia has been widely
evaluated in recent years [15], only few studies have pro-
vided a detailed description of the costs of hospital ad-
mission among people with dementia taking their living
situations into consideration [16]. This information may
be helpful for the planning of the provisions of care.
Thus, there is a lack of studies that describe and com-
pare the frequency of hospital admission in both the
community and NH settings, investigate and compare
the factors associated with hospital admission in both
settings, and provide information on its costs.
Aim
The aims of the present study were: 1) to describe the
frequency of hospital admissions (including Emergency
Department), among people with dementia from eight
European countries living in the community and those
living in nursing homes; 2) to examine the factors asso-
ciated with hospital admissions among people with de-
mentia living in the community and those living in
nursing homes settings, separately; 3) to evaluate the
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costs associated with hospital admissions according to
the different living situations.
Methods
Design
This study is a secondary analysis of a large European
research project called ‘RightTimePlaceCare’ (RTPC).
The RTPC survey was a longitudinal prospective study,
conducted in eight European countries (Estonia, Finland,
France, Germany, Netherlands, Spain, Sweden, and the
United Kingdom). The project aimed to improve health
and social care services for European citizens with de-
mentia and focused on the transition from professional
home care towards institutional nursing care. Further
details are published elsewhere [17].
Participants
The RTPC survey comprised two groups of participants:
1) People with dementia newly admitted to NH (i.e.
within one to 3 months after admission) and their
informal caregivers; 2) People with dementia who re-
ceived professional home care and were at risk of
institutionalization (as judged by a professional respon-
sible for their care) along with their informal caregivers.
Informal caregivers could include spouses/partners,
other family members, relatives, friends, neighbours or
other unpaid individuals within their social network
[18]. The number of informal caregivers was limited to
one main informal caregiver per person with dementia,
defined as the person who was most involved in care for
the people with dementia. For people living in NH, the
next of kin or significant other was included, being the
person closest to the person with dementia (spouse, chil-
dren, grandchildren, other relatives, or friends) and who
was most involved in decisions about their care.
Inclusion criteria for people with dementia were if they
(1) had a primary diagnosis of dementia as diagnosed by
an expert (e.g. physician, psychiatrist, neurologist, geria-
trician, or general practitioner, depending on countries’
diagnostic procedures) and recorded in the medical re-
cords; (2) scored 24 points or lower on the Standardized
Mini Mental State Examination (S-MMSE) [19]; and (3)
had an informal caregiver who visited the people with
dementia at least twice a month. People with dementia
were excluded when they (1) were younger than 65
years; (2) had a primary psychiatric diagnosis or Korsak-
off syndrome; and, for the group recently admitted to
NH, (3) were only temporarily resident in the NH (e.g.
rehabilitation, respite of the informal caregiver) with the
intention of moving back home.
Procedures
Each country obtained ethical approval from a country
specific legal authority for research on human beings
(for example an ethical committee specialized in medical
or nursing science) to conduct the study in accordance
with their national standards and regulations. Country-
specific consent procedures were followed.
Data were collected by trained interviewers at baseline
between November 2010 and April 2012 and follow-up
interviews were conducted after 3 months [17]. All inter-
viewers were professionals in health or social care or
medical/nursing/social care students with practical
experience and at least a Bachelor’s degree.
Measures
Sample characteristics
At baseline, information on the age, sex, country and liv-
ing situation (i.e. home care (HC) vs nursing home
(NH)) of the people with dementia was collected. Cogni-
tive status was assessed with the S-MMSE (range 0–30),
with higher scores indicating less cognitive impairment
[19]. The disease severity was defined as mild (S-MMSE
> 21), moderate (10–21), or severe (< 10) [20]. Partici-
pants who were unable to perform the S-MMSE due to
cognitive or functional impairment were placed into the
“severe dementia” group. Medical history of past and
current clinical conditions were recorded based on the
Charlson Comorbidity Index (CCI) (range 0–37), with
higher scores indicating more clinical conditions and a
score > 2 indicating moderate comorbidity [21]. Inde-
pendence in activities of daily living (ADL) was mea-
sured by the Katz index (range 0–6); we categorised
dependency as mild (Katz index 5–6), moderate (2–4),
or severe (< 2) [22]. Behavioural and psychiatric symp-
toms in dementia were evaluated with the Neuropsychi-
atric Inventory Questionnaire (NPI-Q). The NPI-Q
comprises 12 domains (e.g. agitation and aggression, de-
lusions, hallucinations) with 2 scores reported for each
domain: (1) presence of symptoms and (2) severity on a
0–3 scale (0 = none, 1 =mild, 2 =moderate, 3 = severe;
range 0–36), with higher scores indicating more (severe)
symptoms [23].
Furthermore, several quality of care indicators based
on recent literature [24] were assessed at baseline: nutri-
tional status (one item question ‘did the person experi-
ence a weight loss of 4% or more of his/her weight in
the past year?’) [25, 26], polypharmacy (≥5 drugs) [27]
and the occurrence of falls during the preceding 3
months. Fall was defined as “an unexpected event in
which the participant comes to rest on the ground, floor,
or lower level” [28].
With regard to the informal caregivers, data on their
age, sex and relationship with the person with dementia
were collected. In addition, caregiver burden was mea-
sured using the Zarit Burden Interview (ZBI) [29]. Infor-
mal caregivers responded to 22 statements relating to
the care of their relative with dementia using a Likert
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scale scoring system which ranged from “Never” to
“Nearly Always”. Total scores range from 0 to 88, with a
higher score indicating higher perceived burden; three
severity groups were defined: little or no burden (ZBI < 21),
mild burden (ZBI ≥21–40), or moderate to severe burden
(ZBI > 40) [30].
In the HC setting, information on independence in
ADL, behavioural and psychiatric symptoms in dementia
and quality of care indicators was asked to the informal
caregivers of the people with dementia, while in the NH
setting, this information was asked to the formal care-
givers, as they were considered best informed proxies.
All measurement instruments were selected based on
their psychometric properties (validity, reliability), clin-
ical utility and appropriateness for the target settings
and population [17].
Information on emergency department and hospital
admissions
The Resource Utilization in Dementia (RUD) instrument
was used to determine the health care resources used for
people with dementia [31]. The RUD instrument cap-
tures medical care resources use (e.g. medication, in-
patient and outpatient care), community care services
(e.g. home care, transportation, meals on wheels, day
care), special accommodation (e.g. nursing home) and
time spent with caring activities by informal caregivers.
Information on hospital visits since the baseline inter-
view was gathered using an adapted version of the RUD
instrument in the follow-up assessment that included
the two concepts Hospital Admission (HA) and Emer-
gency Department Admissions (EDA). In the HC setting,
this information was asked to the informal caregivers,
while in the NH setting, this information was asked to
the formal caregivers, as they were considered best in-
formed proxies. With regard to HA, caregivers were
asked: “since the last visit, was the person with dementia
admitted to a hospital (for more than 24 hours)?”; “how
many times was your relative/the resident hospitalised?”;
“for each hospitalisation, please provide the diagnosis or
reasons for hospitalisation”; “for each hospitalisation,
please specify the total number of nights spent in each
type of ward”. The following types of ward were asked
about: geriatric ward, surgery ward, internal medicine
ward, psychiatry ward and other hospital stays. If the an-
swer “other” was given, the caregiver was asked to spe-
cify the type of ward by means of an open question.
With regard to EDA, caregivers were asked: “Since the
last visit, did the person with dementia receive care in
an accident and emergency hospital department (for less
than 24 hours)?”; and if yes, “how many times”? Partici-
pants with at least one episode of HA or EDA were
considered to have experienced a hospital visit.
Estimate of cost for emergency department and hospital
admissions
While the costs of dementia were previously measured
from a societal perspective in the RTPC project [33–35],
our study focused on the assessment of direct medical
costs generated by EDA and HA and calculated as aver-
age costs per capita and year in Euros (€). In the absence
of valid and comparable unit costs for all participating
countries, a common price vector based mainly on
Swedish sources was used for all countries [33, 36]. For
HA, the length of stay in each medical department was
taken into account in the measurement. In the case of
fees not being available for daily stay in departments
other than internal medicine, geriatrics or surgery it was
decided to assume a cost per day similar to the daily ex-
pense in the department of geriatrics. In addition, we
calculated the average costs per capita and year specific-
ally among those people with dementia who had suffered
≥1 hospital admission. All costs were inflated to the year
2019 and currency conversion adjustments based on
2019 exchange rates were made for the non-EURO
countries. Cost components, unit costs, the international
adjustment schemes and their sources are shown in
Table 1 [32, 36, 37].
Statistical analyses
The characteristics of people with dementia and their in-
formal caregivers as well as the HA and EDA episodes
are described using means and standard deviations (SD)
for continuous variables with normal distribution,
median, first and third quarter for continuous variables
without normal distribution, and percentages for
discrete variables. The assessment of the hospitalisation
rates was made taking into account the estimated annual
emergency department and hospital admissions, respect-
ively, in addition to the total number of people with
dementia participating in the study.
Univariate analyses were used to evaluate the inde-
pendent variables (CCI, S-MMSE, Katz Index, NPI-Q
scores, ZBI, weight loss, polypharmacy, falls and setting)
potentially associated with the occurrence of a Hospital
Admission (at least one episode of HA or EDA). Vari-
ables were chosen after literature-based team discussion.
Mann-Whitney’s U test was used for continuous vari-
ables, as the distribution of the variables was not normal
and the number of cases was small. Fisher’s exact test
was preferred when the software was available to calcu-
late it (all categorical variables except country), even
though the approximation using the Chi-square test was
good because of sufficient sample size in all categories
[38]. All variables were included in a logistic regression
model. The different independent variables were tested
on multicollinearity in order to identify potential inter-
actions between them.
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All analyses considered a significance level α of 0.05
(two-sided) and were conducted with IBM SPSS Statis-
tics version 25 (IBM Corporation, Chicago, IL).
Results
Sample characteristics
The total RTPC sample at baseline comprised 2014
dyads of people with dementia and their informal care-
givers. For the present study, only participants with data
available on EDA and HA were included. Thus, the
study sample comprised 1700 people with dementia and
their informal caregivers (n = 1054 (62%) from the HC
setting and n = 646 (38%) from the NH setting).
The mean age of the study sample was 82.8 years
(standard deviation (SD) 6.5), and 68.5% were women.
The characteristics of the study participants (people with
dementia and informal caregivers) are summarized in
Table 2 and Additional file 1, respectively.
Emergency department or hospital admissions
Table 3 describes the frequencies of EDA and HA in
both settings as well as, for HA, the frequencies of ad-
mission and the average length of stay in days in the
different medical departments evaluated.
Two-hundred and eighty-four of the people with de-
mentia (16.7%) experienced at least one EDA (< 24 h) or
HA between the baseline and follow-up assessments,
with a higher frequency in the HC group (NH: 89
(13.8%) vs HC: 195 (18.5%); p = 0.011). The majority of
the people with dementia living at home and in nursing
home who suffered at least one EDA within the 3
months had only one episode of EDA, with a minority of
them suffering two or more EDA. A similar situation
occurred for HA episodes.
We found an overall estimated HA rate per person
with dementia/year of 0.44 and EDA rate per person
with dementia/year of 0.37, with an estimated rate of
HA per person with dementia/year of 0.35 among per-
sons living in NH and 0.50 among those living in HC,
and an estimated rate of EDA per person with
dementia/year of 0.26 among persons living in NH and
0.43 among those living in HC.
Some differences were found with regard to the types
of departments where people with dementia were admit-
ted, depending on their living situations.
Factors associated with emergency department and
hospital admissions
Table 4 displays the univariate and multivariate analyses
on the factors potentially associated with having at least
one EDA or HA for each setting. The multivariate ana-
lyses showed that, for people with dementia living in
NH, polypharmacy was associated with having at least
one EDA or HA (OR 1.96, CI (1.03–3.75)). With regard
to the people with dementia living in HC, the factors in-
dependently associated with hospital admission were:
the presence of falls in the preceding 3 months (OR 1.64,
CI (1.12–2.41)), polypharmacy (OR 2.48, CI (1.70–3.62)),
weight loss (OR 1.73, CI (1.17–2.56)), mild caregiver
burden compared with little or no burden (OR 1.67 CI
(1.04–2.66)), and moderate to severe caregiver burden
compared with little or no burden (OR 1.76, CI (1.04–
2.98)). No statistically significant association was found
between hospital admission and functional or cognitive
status of participants in either NH or HC.
Costs of emergency department and hospital admissions
Table 5 shows the estimated health cost per person with
dementia/year according to country and setting (NH vs
HC). On average, for the whole study sample, the esti-
mated medical cost per person with dementia/year re-
lated to EDA and HA was 1884.28€, with 1046.19€ per
person with dementia/year in NH group and 2397.96€ in
HC group. Concerning the estimated average expend-
iture per person with dementia/year for EDA, this was
67.30€ in the NH group and 117.48€ in the HC group.
For HA an estimated average cost per person with de-
mentia/year of 978.89€ was obtained in the NH group,
and 2280.48€ in the HC group. On average, for the
whole study sample, we found higher expenses per
Table 1 Unit costs and international price adjustments (inflated to the year 2019a)
Estonia Finland France Germany Netherlands Spain Sweden UK
International price adjustment
Exchange rates; local currency / Euro 1.00 1.00 1.00 1.00 1.00 1.00 10.59 0.87
Medical Care (Inpatient care)
Costsb per day hospital (geriatric) 92.14 318.60 313.82 293.41 280.82 162.22 335.25 256.98
Costs per day hospital (internal medicine) 101.27 350.18 344.92 322.50 308.64 179.13 368.50 282.45
Costs per day hospital (surgery) 148.87 514.74 507.01 474.05 453.69 263.31 541.63 415.19
Costs Emergency room visit 63.06 218.14 214.86 200.89 192.27 111.59 229.54 175.94
a Last available official statistics by the Organisation for Economic Co-operation and Development (OECD). Prices, purchasing power parities (PPP) and Exchange
rates [32]
bCosts are expressed in Euros
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person with dementia/year in both ED and HA visits for
people with dementia living in the HC setting compared
to those living in the NH setting, except in the
Netherlands, where a higher expenditure on hospitalisa-
tion of people with dementia living in NH was found,
despite the global EDA and HA cost per person with de-
mentia/year being lower than the HC group. A greater
estimated cost per person with dementia/year for EDA
was also found in the NH group in France and
Germany.
Discussion
In this cross-sectional study, 1700 people with dementia
from eight European countries participating in the RTPC
study were investigated. The estimated rate of hospital
admission per person with dementia/year of 0.35 among
people living in NH and 0.50 among those living in HC,
and an estimated rate of emergency department
admission per person with dementia/year of 0.26 among
people living in NH and 0.43 among those living in HC.
In the HC setting, factors identified as being associated
with a higher probability of suffering at least one EDA
or HA were: suffering weight loss, accidental falls, pre-
senting polypharmacy and having a caregiver with mild
to severe burden compared with little or no burden. In
the NH setting, only polypharmacy was associated with
a higher probability of suffering at least one EDA or HA.
Concerning health costs, a higher estimated cost per
person/year attributable to hospital admission (EDA and
HA) was observed for people with dementia included in
the HC group as compared to the NH group.
With regard to community-dwelling people with de-
mentia, our results of estimated rate of hospitalisation
are within the range of hospitalization rates presented by
Shepherd et al. in their systematic review of the litera-
ture (rates of 0.37–1.26 per person/year) [9]. When







Age (years), mean (SD) 83.8 (6.5) 82.1 (6.5) 82.8 (6.5)
Women, n (%) 486 (75.2%) 679 (64.4%) 1165 (68.5%)
S- MMSE (range 0–30)a,b, median (Q1;Q3) 13 (8;17) 15 (10;20) 14 (9;19)
Missing values 128 130 258
Katz Index (range 0–6)a, median (Q1;Q3) 2 (1;4) 3 (2;5) 3 (1;5)
Missing values 2 11 13
Charlson Comorbidity Index (range 0–37)a, median (Q1;Q3) 2 (1;3) 2 (1;3) 2 (1;3)
Severity of neuropsychiatric symptoms (range 0–36)a, median (Q1;Q3) 5.5 (3;10) 8 (4;13) 7 (3;12)
Zarit Burden Interview (range 0–88)a, median (Q1;Q3) 21 (13;33) 31 (20.9;43) 27 (17;39.2)
Missing values 3 3 6
Weight loss (≥4%, yes), n (%) 81 (13.0%) 211 (20.6%) 292 (17.7%)
Missing values 25 28 53
Polypharmacy (≥5 drugs, yes), n (%) 440 (68.1%) 604 (57.3%) 1044 (61.4%)
Mean number of drugs (SD) 6.0 (3.1) [6] 5.3 (3.1) [5] 5.5 (3.1) [5]
Falls in preceding 3 months (baseline) 172 (26.7%) 215 (20.4%) 387 (22.8%)
Missing values 3 1 4
Country, n (%)
United Kingdom 55 (8.5%) 60 (5.7%) 115 (6.8%)
Estonia 80 (12.4%) 145 (13.8%) 225 (13.2%)
Finland 111 (17.2%) 157 (14.9%) 268 (15.8%)
France 35 (5.4%) 151 (14.3%) 186 (10.9%)
Germany 99 (15.3%) 91 (8.6%) 190 (11.2%)
Netherlands 104 (16.1%) 165 (15.7%) 269 (15.8%)
Spain 85 (13.2%) 155 (14.7%) 240 (14.1%)
Sweden 77 (11.9%) 130 (12.3%) 207 (12.2%)
Missing values declared when present
SD Standard Deviation, Q1 First quartile, Q3 Third quartile
a Underlined scores indicate the direction of a better outcome
bOnly participants with scores of lower than 24 points were included
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comparing our results on hospitalisation rates among
people with dementia living in NH, the few studies exist-
ing for this setting report on disparing results, with
Maxwell et al. (2018) reporting a rate of 0.21 person/year
[10], and Feng et al. (2014) reporting a rate of 0.46 [39].
People with dementia living at their homes had higher
rates of EDA or HA than those in the NH setting in the
present study. Reasons for this may have been that care-
givers of people with dementia who live at home may
have had less support in managing health needs or
higher levels of care burden [40], leading to a greater
need for emergency service utilization and hospital ad-
mission. Other reasons for lower hospital transfer needs
in the nursing home setting compared with home care
suggested in the literature are that, even if EDA rates
from nursing home are high [8], some of these institu-
tions may be equipped with specific care units for people
with advanced dementia [41], have a wider availability to
perform post-acute attention [42], receive specialized
health support from geriatric [43] or end-of-life care
more frequently, and they may have policies to prevent
transferring those persons to hospital.
Sleeman et al. also found in a retrospective cohort
study of 4867 people with dementia in their last year of
life in England, that being in a nursing home was associ-
ated with a significantly lower number of ED visits [43].
The authors argued that increasing bed capacity in NHs
may have explained their results, as it may have allowed
more people with advanced dementia dying in the NH.
Maxwell et al. also reported on lower hospitalisation
rates among people with dementia living in NH com-
pared with those living in assisted living facilities, and
attributed this difference to the insufficient capacity of
assisted living facilities to cover the needs of people with
dementia [10].
Conversely, another report analyzing the impact of de-
mentia on hospital and ED use among fee-for-service
Medicare beneficiaries reported that people with demen-
tia who lived in nursing homes were significantly more
likely to visit the emergency department and be hospita-
lised than those who resided in their own homes [29].
In the HC setting, polypharmacy was associated with
hospital admission, in the line with the results by Shep-
herd et al., who found moderate confidence in this
Table 3 Description of Emergency Department Admissions (EDA) and Hospital Admission (HA), by setting
Nursing Home (n = 646) Home Care (n = 1054) Overall (n = 1700) p_value****
PwD* with at least 1 EDA or 1 HA**, n (%) 89 (13.8%) 195 (18.5%) 284 (16.7%) 0.011
PwD with at least 1 EDA (with < 24 h stay), n (%) 48 (7.4%) 123 (11.7%) 171 (10.1%) 0.005
PwD with valid number of EDA*** 43 115 158
PwD with 1 admission, n (%) 33 (76.7%) 81 (70.4%) 114 (72.2%)
PwD with 2 or more admissions, n (%) 10 (23.3%) 34 (29.6%) 44 (27.8%)
Rate of EDA per PwD/year 0.26 0.43 0.37
PwD with at least 1 HA (with > 24 h stay), n (%) 58 (9.0%) 135 (12.8%) 193 (11.4%) 0.018
PwD with valid number of HA*** 57 133 190
PwD with 1 admission, n (%) 50 (87.7%) 103 (77.4%) 153 (80.5%)
PwD with 2 or more admissions, n (%) 7 (12.3%) 30 (22.6%) 37 (19.5%)
Rate of HA per PwD/year 0.35 0.50 0.44
Department of HA, n (%)
Geriatric 5 (10%) 49 (35%) 54 (28%)
Internal Medicine 15 (31%) 41 (29%) 56 (29%)
Surgical 20 (41%) 20 (14%) 40 (21%)
Other 11 (22%) 30 (21%) 41 (22%)
Length of stay during HA admission in days, median (Q1;Q3)
Geriatric 8 (5;16) 8 (6;11) 7.5 (6;11)
Internal Medicine 11 (4;15) 8 (6;17) 7.5 (5;17)
Surgical 6.5 (3;17) 8.5 (4;11) 7 (3;15)
Other 3 (2;6) 9 (6;18) 7 (4;14)
Note: Q1 first quartile, Q3 third quartile
*: PwD: People with Dementia
**: A PwD may have suffered both EDA and HA episodes
***: Data on the number of EDA or HA available only for these participants
****: p values provided only for the main descriptive variables on EDA and HA
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association in their meta-analysis [9]. In contrast,
Shepherd et al. found moderate confidence in the associ-
ation of lower level of functional ability with hospitalisa-
tion risk. This association was not found in the present
study. Instead, in the present study significant associa-
tions were found with a history of falls within the previ-
ous 3 months and with the presence of weight loss.
These factors were not evaluated by Shepherd et al. in
their meta-analyses. Interestingly, the authors suggest in
their discussion that it can be difficult to ascertain
whether loss of functionality may be connected with
other adverse outcomes such as side effects of medica-
tion or even malnutrition or weight loss. This might
explain the differences between their results and those
of the present study.
So far, unintentional weight loss has been found asso-
ciated with increased morbidity and mortality among
older adults [44], but to the best of our knowledge the
relationship between unintentional weight loss in people
with dementia and the risk of hospitalisation has not
been well established [9, 45]. In previous reports, but in
older populations, malnutrition has been associated with
an almost fourfold increased risk of readmission or mor-
tality within 7 days of discharge from a hospital, and the
risk almost doubled between 8 and 180 days after dis-
charge [46].
Conversely, falls are of great concern for people
with dementia given their potentially higher number
of visits to emergency departments and severe conse-
quences, mainly hip fracture [47]. Our results are
aligned with those reported by Toot et al. on the risk
of admission associated with osteoarticular conditions
(eg: falls/fractures) in people with dementia living in
the community [48].
The severity of dementia was not associated with
hospital admission, which is consistent with the results
presented by Shepherd et al. in their meta-analyses, who
reported moderate confidence in this finding [9].
Conversely, higher comorbidity was not associated
with hospital admission in the present study, in contrast
with the results by Shepherd et al., who graded their
confidence with this result as moderate. However, in
their discussion, the authors reported on a study [49]
that described an increased risk of hospitalisation only
because of the presence of dementia as comorbidity, ir-
respective of the existence of any further comorbid
conditions.
Currently, evidence for effective interventions to re-
duce the risk of falls, to reduce polypharmacy and to im-
prove nutrition is limited and requires further
development [50–53]. Nevertheless, the results of the
present study suggest that the identification and
Table 5 Estimated average annual medical costs per person with dementia in the RTPC sample (n = 1700) a, b,c






















48 (56) 124 (164) 56 (68) 84 (108) 72 (144) 136 (200) 36 (108) 76 (96) 632 (944)
Cost (NH) 6.31 62.89 122.78 121.75 51.77 52.51 35.77 127.96 67.30
Cost (HC) 20.87 183.41 68.30 105.96 135.17 115.19 169.51 164.21 117.48
Total cost of EDA 15.69 133.49 78.55 114.19 102.93 92.99 119.76 146.87 98.41




72 (816) 148 (2656) 176 (1832) 140 (1072) 44 (204) 56 (1012) 56 (1308) 72 (1000) 764 (9900)
Cost (NH) 215.86 1092.88 1326.99 1464.11 353.11 397.94 2005.59 1229.82 978.89
Cost (HC) 459.23 5340.47 3632.84 2429.68 153.14 1372.76 3028.60 1619.27 2280.48
Total cost of HA 372.70 3581.21 3198.94 1926.57 238.17 1059.53 2648.13 1433.01 1785.87
Estimated n of people with
dementia
with hospital episodes
(EDA episodes and HA episodes)
120 272 232 224 116 192 92 148 1396
Cost (NH) 222.17 1155.77 1449.77 1585.86 424.83 540.84 2041.56 1357.78 1046.19
Cost (HC) 480.10 5523.87 3701.13 2535.65 288.31 1487.96 3198.11 1783.48 2397.96
Total cost of hospital episodes 388.39 3714.70 3277.49 2040.76 341.09 1152.52 2767.89 1579.89 1884.28
EDA Emergency Department Admissions, HA Hospital Admissions
aAll expenses refer to costs per person with dementia, according to setting and country
bCosts calculated including only people with dementia with data available on the number of EDA or HA
cAll costs expressed in €
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management of these three geriatric syndromes might
help preventing hospitalisation events among people
with dementia living at home. Furthermore, the promo-
tion of an advanced and individualised care plan among
people with dementia showing these geriatric syndromes
may be particularly advisable.
Mild to severe levels of caregiver burden were associ-
ated with hospital admission for people with dementia
living in the HC setting in the present study. This result
is in the line with the results by Guterman et al. [14]
and Maust et al. [40], which found a significant associ-
ation between mental health and caregiver distress, re-
spectively, and ED use by people with dementia living in
the community. Future interventions to reduce unneces-
sary hospitalisations should also focus on providing sup-
port to the caregivers of people with dementia living at
home.
In the NH setting, only polypharmacy was associated
with hospital admission among people with dementia in
the present study, suggesting that there is a special need
to target this geriatric syndrome for this population, in
order to reduce unnecessary hospitalisations [54, 55].
In the present study, it was observed that medical
costs associated with hospital admission (including
EDA) were higher in the HC setting, results that can be
explained by the higher frequency of HA and EDA
found among people with dementia living at home.
Similar to our results, Coots Daras et al. (2017) found
that people with dementia in their last year of life living
in NH had lower costs derived of EDA and HA than
people with dementia living in the community. However,
these results were not seen among the general popula-
tion with dementia, for whom the costs of EDA and HA
were higher among those living in NH [16]. The authors
discuss that expenditures associated with hospital and
ED use may vary by residential setting, and proximity to
death.
Our results suggest that interventions aimed at pre-
venting EDA and HA among people with dementia may
be cost-effective, especially in the HC setting, as for
most countries the costs associated with EDA and HA
were higher in these setting. However, the results should
be interpreted with caution, as costs of other interven-
tions that may be put in place when acute events occur
such as specialized health support teams or specific care
units for advanced dementia have not been taken into
consideration. Differences between countries with regard
to the implementation of such interventions, as well as
potential country differences in the characteristics of the
people with dementia living in each of the settings [56]
and potential country differences in the way how de-
mentia care is provided [57], may explain the country
differences seen in the costs of hospitalisation. Further-
more, these results should be seen within the framework
of the overall costs of dementia care. Interestingly, a pre-
vious analysis of the costs of dementia care within the
RTPC study showed higher costs for the care provided
at NH compared with those provided at HC, with the
particularity that the costs in the HC setting increased
with the severity of dementia [33].
The findings of our study should be interpreted con-
sidering its limitations. Firstly, there might have been a
number of people with undiagnosed dementia who were
not included in the present study due to its inclusion
criteria (formal diagnosis of dementia); these people,
who may also be admitted to hospital for several reasons
with the corresponding costs associated, could not be
described in the present study. Secondly, the time period
investigated for each participant was limited to 3
months, which may not represent the entire population
of people with dementia requiring hospital admission
over the one-year period, taking into account seasonal
fluctuations; however, the prospective character of the
study may have facilitated the acquisition of reliable
data. Furthermore, the RTPC country samples may not
be representative of the general national population of
people with dementia. Thirdly, although we accounted
for multiple variables that may affect the need for hos-
pital admission, there may also be additional unmeas-
ured confounding factors that influence the use of
hospital care, for example, specific health support at the
community or nursing home setting in each country or
even at the local level. Finally, several years have passed
between data compilation and secondary analysis. How-
ever, we believe that the present study adds relevant
value to the body of literature with regard to the com-
parison of the frequency of hospitalisation between the
NH and HC settings among people with dementia,
factors associated and costs, in a world where the
organization of long-term-care is still a challenge [58].
Conclusions
To the best of our knowledge, this is the first study that
evaluates internationally (across Europe) the frequency
of hospitalisation among people with dementia living in
nursing homes and home care settings, and analyses the
associated factors and costs for each setting.
Admission to hospital is frequent among people with
dementia, especially among those living in the commu-
nity, and seems to impose a remarkable economic
burden. The identification and establishment of an indi-
vidualized care plan for those people with dementia with
polypharmacy in nursing homes, and those with invol-
untary weight loss, accidental falls, polypharmacy and
higher caregiver burden in the home care setting, might
help preventing unnecessary hospital admissions and
saving associated costs.
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